Blood filter during heart surgery may prevent organ failure

NCT ID NCT07532174

Recruiting now Disease control Sponsor: Efferon JSC Source: ClinicalTrials.gov ↗

First seen Apr 26, 2026 · Last updated May 02, 2026 · Updated 3 times

Summary

This study tests a device called Efferon LPS that filters the blood during and shortly after heart surgery. The goal is to see if it can reduce the risk of multiple organ dysfunction syndrome, a serious complication where several organs start to fail. About 60 adults having heart surgery with a heart-lung machine will take part. The device is used once during surgery and once within 24 hours after.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Almazov National Medical Research Centre
RECRUITING

Saint Petersburg, Russia

Contact Email: •••••@•••••
Pavlov First Saint Petersburg State Medical University
RECRUITING

Saint Petersburg, Russia

Contact Email: •••••@•••••
Regional State Budgetary Healthcare Institution "Altai Regional Cardiological Dispensary"
RECRUITING

Barnaul, Russia

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARDIAC DISEASE MULTIPLE ORGAN DYSFUNCTION SYNDROME